Actively Recruiting
Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation
Led by Zhongshan Ophthalmic Center, Sun Yat-sen University · Updated on 2022-01-11
228
Participants Needed
1
Research Sites
606 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare the incidence of glaucoma-related adverse events of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia
CONDITIONS
Official Title
Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged between 18 months and 14 years
- Had a primary diagnosis of congenital cataract
- Underwent cataract extraction between the ages of 2 and 24 months
You will not qualify if you...
- Primary IOL implantation
- Pre-existing ocular disease which might affect the location and outcome of secondary IOL implantation (including and not restricted to microphthalmia, microcornea, corneal opacity, pseudopterygium, iris anomaly, glaucoma diagnosed before cataract extraction, uveitis, persistent fetal vasculature or trauma)
- Suture fixation for secondary IOL implantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China, 510060
Guangzhou, China, 510060
Actively Recruiting
Research Team
Z
Zhenzhen Liu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here